Learn Before
Molecular Underpinnings of COVID-19 and the Cardiovascular System
Angiotensin-converting enzyme 2 (ACE2)is a membrane bound protein that functions as a receptor for SARS-CoV-2. Since ACE2 is found in the lungs and heart, systemic inflammatory response triggered by the virus will target those tissues, leading to damage in myocardial cells. This will lead to an increase in cardiovascular symptoms in COVID-19 patients.
- RAAS and COVID-19
- ACE Inhibitors and Angiotensin Receptor Blockers
- Troponin
1
3
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Disability Studies
Social Science
Empirical Science
Science
Learn After
Factors that can potentially increase ACE2 expression in the Cardiovascular System
Inhibitors of the Renin–Angiotensin–Aldosterone System (RAAS) and COVID-19
Studying the effect of ACE inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) in COVID-19 Patients with Hypertension (Wuhan, China)
Troponin and cardiovascular disease in relation to COVID-19